Sign In
Buy GLP
$48.46
-0.170 (-0.350%)
At Close: Jul 29, 2026
Global Partners Announces Cash Distribution on Series B Preferred Units
08:30am, Monday, 12'th Jan 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Global Partners LP (NYSE: GLP) (the “Partnership”) today announced that the Board of Directors (the “Board”) of its general partner, Global GP LLC, has declare
Biomea Fusion Enters 2026 Focused on Executing Key Icovamenib and BMF-650 Milestones
08:00am, Monday, 12'th Jan 2026
Advancing icovamenib toward late-stage clinical development in two Phase II clinical trials in patients with insulin-deficient type 2 diabetes (“T2D”) and in T2D patients currently failing glucago
Publication Highlights Impressive Weight Loss of Up to 14.7% from Baseline After 13 Weeks of Treatment; No Plateau Observed VK2735 Currently Being Evaluated in VANQUISH Phase 3 Registrational Program
The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth
08:59am, Saturday, 10'th Jan 2026
Eli Lilly (NYSE: LLY) and Johnson & Johnson (NYSE: JNJ) both delivered strong third-quarter results, but their earnings revealed two fundamentally different healthcare businesses.
2026 is the year of obesity pills. Here's how they could reshape the GLP-1 market
08:00am, Saturday, 10'th Jan 2026
In 2026, new obesity pills will push the booming GLP-1 market into its next chapter. Pills may serve as a more convenient — and in certain cases cheaper — alternative to today's blockbuster inject
Novo Nordisk and Eli Lilly can both gain GLP-1 market share this year, says Citi's Meacham
06:22pm, Friday, 09'th Jan 2026
Geoff Meacham, Citi analyst, joins 'Fast Money' to talk what the year ahead holds for competition in the obesity drug market.
Chipotle's High-Protein Push Targets GLP-1 Users, Analysts See Upside
01:04pm, Friday, 09'th Jan 2026
Chipotle Mexican Grill, Inc. (NYSE: CMG) shares are trading higher on Friday.
LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform
06:00pm, Thursday, 08'th Jan 2026
VANCOUVER, BC / ACCESS Newswire / January 8, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790) (WKN: A41QA9) ("LIR" or the "Company") is pleased to announce that it has entered
Hims & Hers: Looking Beyond GLP-1s To The Next Phase Of Global Growth
09:18am, Thursday, 08'th Jan 2026
Hims & Hers Health is significantly undervalued, with the market underestimating its growth potential and international expansion opportunities. Geographical and product expansion, vertical integratio
Omada Health's GLP-1 Behavior Change Companion Programs Help Drive Lasting, Long-Term Weight Loss
09:00am, Thursday, 08'th Jan 2026
SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced results from a 12-month real-world analysis of memb
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced the selection of AMX0318, a long-acting glucagon-like peptide-1 (GLP-
Warning: This Skyrocketing Stock Has a Hidden Risk
08:30pm, Tuesday, 06'th Jan 2026
Novo Nordisk was the first company to introduce a GLP-1 shot. Eli Lilly's GLP-1 shot quickly became the industry leader after its introduction.
Should Investors Be Concerned About This Pharmaceutical Giant's Latest Clinical Trial?
06:00pm, Tuesday, 06'th Jan 2026
Novo Nordisk has released a pill version of its GLP-1 drug. In 2025, the company announced that it was ending a GLP-1 trial related to the drug's impact on Alzheimer's.
Novo Nordisk launches first oral GLP-1 weight loss pill in the US
11:40am, Monday, 05'th Jan 2026
Novo Nordisk (NYSE:NVO) has made its Wegovy pill, the first oral GLP-1 treatment for weight loss, broadly available to patients in the United States. The launch marks a new development in obesity trea
Is It Time to Dump Your Shares of Eli Lilly?
09:00am, Monday, 05'th Jan 2026
Novo Nordisk was the first company to introduce GLP-1 weight loss drugs. Eli Lilly's GLP-1 drugs have since taken the lead in the emerging weight loss space.
